MESO-Rx Newsletter

[swp-forms id=13792]

Mark McGwire’s Little Helper: The Androstenedione Debate

In 1935 -- the year testosterone was first synthesized in the laboratory -- the Food and Drug Administration established a unit to monitor the quality of the numerous "glandular" products on the market that were … [Read More...] about Mark McGwire’s Little Helper: The Androstenedione Debate

Deeper Into Prostaglandin Use

Many readers enjoyed my previous article about prostaglandins as muscle builders. This short introduction to prostaglandins produced critics, controversies and queries. Prostaglandins, especially PGF2 are no wonder … [Read More...] about Deeper Into Prostaglandin Use

Muscle Profiling – Is Muscularity Evidence of a Crime?

Muscularity (mesomorphy) has a long-time alleged association with negative characteristics such as assertiveness or even criminality (e.g., Sheldon, 1942). The modern pursuit of muscle has also been demonized via … [Read More...] about Muscle Profiling – Is Muscularity Evidence of a Crime?

Protein, Part 3: Individual Amino Acid Requirements

In Part 2 of this series, the topic of protein quality was discussed, including examination of the major methods currently used to rate protein quality. For a variety of reasons, most of the currently available … [Read More...] about Protein, Part 3: Individual Amino Acid Requirements

The Science of Trenbolone, Part 3

We are going to dig more into trenbolone’s anabolic properties in this part of the article series. It is worth reiterating that all studies relevant to today’s topics were performed on animals. So, my goal is to … [Read More...] about The Science of Trenbolone, Part 3

MESO-Rx Newsletter

MESO-Rx International

Questions? Comments?

Search

Footer

MESO-Rx International

Questions? Comments?

Search